Inhibitory effect of ebselen on cerebral acetylcholinesterase activity in vitro: kinetics and reversibility of inhibition
- PMID: 25312723
- DOI: 10.2174/1381612820666141014124319
Inhibitory effect of ebselen on cerebral acetylcholinesterase activity in vitro: kinetics and reversibility of inhibition
Abstract
Ebselen is a synthetic organoselenium compound that has been considered a potential pharmacological agent with low toxicity, showing antioxidant, anti-inflammatory and neuroprotective effects. It is bioavailable, blood-brain barrier permeant and safe based on cellular toxicity and Phase I-III clinical trials. There is evidence that ebselen inhibits acetylcholinesterase (AChE) activity, an enzyme that plays a key role in the cholinergic system by hydrolyzing acetylcholine (ACh), in vitro and ex vivo. This system has a well-known relationship with cognitive process, and AChE inhibitors, such as donepezil and galantamine, have been used to treat cognitive deficits, mainly in the Alzheimer's Disease (AD). However, these drugs have poor bioavailability and a number of side effects, including gastrointestinal upsets and hepatotoxicity. In this way, this study aimed to evaluate the effect of ebselen on cerebral AChE activity in vitro and to determine the kinetic profile and the reversibility of inhibition by dialysis. Ebselen inhibited the cerebral AChE activity with an IC50 of 29 µM, similar to IC50 found with pure AChE from electric eel, demonstrating a mixed and reversible inhibition of AChE, since it increased Km and decreased Vmax. The AChE activity was recovered within 60 min of dialysis. Therefore, the use of ebselen as a therapeutic agent for treatment of AD should be considered, although memory behavior tasks are needed to support such hypothesis.
Similar articles
-
Ebselen inhibits the activity of acetylcholinesterase globular isoform G4 in vitro and attenuates scopolamine-induced amnesia in mice.J Cell Biochem. 2018 Jul;119(7):5598-5608. doi: 10.1002/jcb.26731. Epub 2018 Mar 12. J Cell Biochem. 2018. PMID: 29405440
-
6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.Int J Risk Saf Med. 2015;27 Suppl 1:S69-71. doi: 10.3233/JRS-150694. Int J Risk Saf Med. 2015. PMID: 26639718
-
Pre-treatment with ebselen and vitamin E modulate acetylcholinesterase activity: interaction with demyelinating agents.Int J Dev Neurosci. 2009 Feb;27(1):73-80. doi: 10.1016/j.ijdevneu.2008.09.005. Epub 2008 Sep 27. Int J Dev Neurosci. 2009. PMID: 18930802
-
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.Int J Neuropsychopharmacol. 2006 Feb;9(1):101-24. doi: 10.1017/S1461145705005833. Epub 2005 Aug 5. Int J Neuropsychopharmacol. 2006. PMID: 16083515 Review.
-
Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.Drugs Aging. 2004;21(7):453-78. doi: 10.2165/00002512-200421070-00004. Drugs Aging. 2004. PMID: 15132713 Review.
Cited by
-
Evaluation of the Neuroprotective Effect of Organic Selenium Compounds: An in Vitro Model of Alzheimer's Disease.Biol Trace Elem Res. 2024 Jul;202(7):2954-2965. doi: 10.1007/s12011-023-03893-9. Epub 2023 Oct 7. Biol Trace Elem Res. 2024. PMID: 37803188
-
Seleno-Analogs of Scaffolds Resembling Natural Products a Novel Warhead toward Dual Compounds.Antioxidants (Basel). 2023 Jan 6;12(1):139. doi: 10.3390/antiox12010139. Antioxidants (Basel). 2023. PMID: 36671001 Free PMC article.
-
Toxicology and pharmacology of synthetic organoselenium compounds: an update.Arch Toxicol. 2021 Apr;95(4):1179-1226. doi: 10.1007/s00204-021-03003-5. Epub 2021 Apr 1. Arch Toxicol. 2021. PMID: 33792762 Free PMC article. Review.
-
Ebselen reversed peripheral oxidative stress induced by a mouse model of sporadic Alzheimer's disease.Mol Biol Rep. 2020 Mar;47(3):2205-2215. doi: 10.1007/s11033-020-05326-5. Epub 2020 Feb 24. Mol Biol Rep. 2020. PMID: 32095983
-
New Chiral Ebselen Analogues with Antioxidant and Cytotoxic Potential.Molecules. 2017 Mar 20;22(3):492. doi: 10.3390/molecules22030492. Molecules. 2017. PMID: 28335518 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources